At Fall Clinical 2025, Ron Vender, MD, discussed the evolving psoriasis treatment landscape and the persistent challenge of managing palmoplantar pustulosis.
Ronald Vender, MD, FRCPC
Advertisement
Ronald Vender, MD, FRCPC, is a dermatologist, founder and director of Dermatrials Research Incorporated and Venderm Consulting Inc, associate clinical professor at McMaster University in the Department of Medicine, Division of Dermatology in Hamilton, Ontario, Canada, and an International Psoriasis Council Councilor.
Articles by Ronald Vender, MD, FRCPC
Advertisement
Latest Updated Articles
“From Injectable to Ingestible:” TYK2 Inhibitors for PsO and the Ongoing Challenge of PPPPublished: October 26th 2025 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
